lunes, 4 de mayo de 2020

Big Pharma could boost its reputation with its Covid-19 response - STAT

Big Pharma could boost its reputation with its Covid-19 response - STAT

First Opinion

Big Pharma could boost its reputation with a solid response to Covid-19

By JOHN LAMATTINA


MANDEL NGAN/AFP VIA GETTY IMAGES
Although Big Pharma is investing millions of R&D dollars to find a vaccine or therapy for Covid-19 the industry is being viewed with suspicion and scorn.

No hay comentarios: